Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Compound library design for target families.

Balakin KV, Ivanenkov YA, Savchuk NP.

Methods Mol Biol. 2009;575:21-46. doi: 10.1007/978-1-60761-274-2_2. Review.

PMID:
19727610
2.

Organizing bioactive compound discovery in target families.

Nestler HP.

Methods Mol Biol. 2009;575:1-19. doi: 10.1007/978-1-60761-274-2_1. Review.

PMID:
19727609
3.

Chemogenomics: structuring the drug discovery process to gene families.

Harris CJ, Stevens AP.

Drug Discov Today. 2006 Oct;11(19-20):880-8. Epub 2006 Sep 7. Review.

PMID:
16997137
4.

Structural genomics: the ultimate approach for rational drug design.

Lundstrom K.

Mol Biotechnol. 2006 Oct;34(2):205-12. Review.

PMID:
17172666
5.

Chemogenomics approaches to G-protein coupled receptor lead finding.

Klabunde T, Jäger R.

Ernst Schering Res Found Workshop. 2006;(58):31-46. Review.

PMID:
16708997
6.

A chemogenomic approach to drug discovery: focus on cardiovascular diseases.

Cases M, Mestres J.

Drug Discov Today. 2009 May;14(9-10):479-85. doi: 10.1016/j.drudis.2009.02.010. Epub 2009 Mar 5. Review.

PMID:
19429507
7.

Chemogenomic approaches to rational drug design.

Rognan D.

Br J Pharmacol. 2007 Sep;152(1):38-52. Epub 2007 May 29. Review.

8.

Dimerization of chemokine receptors in living cells: key to receptor function and novel targets for therapy.

Wang J, Norcross M.

Drug Discov Today. 2008 Jul;13(13-14):625-32. doi: 10.1016/j.drudis.2008.04.004. Epub 2008 Jun 3. Review.

PMID:
18598920
9.

G-protein-coupled receptor-focused drug discovery using a target class platform approach.

Heilker R, Wolff M, Tautermann CS, Bieler M.

Drug Discov Today. 2009 Mar;14(5-6):231-40. doi: 10.1016/j.drudis.2008.11.011. Epub 2009 Jan 22. Review.

PMID:
19121411
10.

Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint.

Bender A, Young DW, Jenkins JL, Serrano M, Mikhailov D, Clemons PA, Davies JW.

Comb Chem High Throughput Screen. 2007 Sep;10(8):719-31. Review.

PMID:
18045083
11.

GLIDA: GPCR-ligand database for chemical genomic drug discovery.

Okuno Y, Yang J, Taneishi K, Yabuuchi H, Tsujimoto G.

Nucleic Acids Res. 2006 Jan 1;34(Database issue):D673-7.

12.

The topology of drug-target interaction networks: implicit dependence on drug properties and target families.

Mestres J, Gregori-Puigjané E, Valverde S, Solé RV.

Mol Biosyst. 2009 Sep;5(9):1051-7. doi: 10.1039/b905821b. Epub 2009 Jul 8.

PMID:
19668871
13.

The different strategies for designing GPCR and kinase targeted libraries.

Lowrie JF, Delisle RK, Hobbs DW, Diller DJ.

Comb Chem High Throughput Screen. 2004 Aug;7(5):495-510. Review.

PMID:
15320714
14.

Assay Related Target Similarity (ARTS) - chemogenomics approach for quantitative comparison of biological targets.

Bieler M, Heilker R, Köppen H, Schneider G.

J Chem Inf Model. 2011 Aug 22;51(8):1897-905. doi: 10.1021/ci200105t. Epub 2011 Jul 29.

PMID:
21761911
15.

Chemogenomics knowledge-based strategies in drug discovery.

Jacoby E, Schuffenhauer A, Floersheim P.

Drug News Perspect. 2003 Mar;16(2):93-102.

PMID:
12792670
16.

Chemogenomic approaches for the exploration of GPCR space.

Weill N.

Curr Top Med Chem. 2011;11(15):1944-55. Review.

PMID:
21470168
17.

Thematic Analysis™: a chemogenomic approach to GPCR drug discovery.

Crossley R, Macritchie JA, Slater MJ.

Curr Top Med Chem. 2011;11(15):1925-43. Review.

PMID:
21470170
18.

Large-scale integrated databases supporting drug discovery.

Roter AH.

Curr Opin Drug Discov Devel. 2005 May;8(3):309-15. Review.

PMID:
15892245
19.

Using bioinformatics for drug target identification from the genome.

Jiang Z, Zhou Y.

Am J Pharmacogenomics. 2005;5(6):387-96. Review.

PMID:
16336003
20.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
Items per page

Supplemental Content

Write to the Help Desk